Ye Huiqing, Bai Liyang, Yang Manting, Yang Xiaoyuan, Zheng Maofei, Zhong Xiaobing, Yang Lifen, Chen Zhuanggui, Zhong Xinqi
Department of Neonatology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Pediatrics, The Third Affiliated Hospital of SunYat-sen University, Guangzhou, China.
Front Pediatr. 2023 Jun 14;11:1158286. doi: 10.3389/fped.2023.1158286. eCollection 2023.
Since December 2012, the prophylactic use of caffeine to treat AOP in preterm infants has been approved in China. This study aimed to investigate the relationship between early caffeine treatment initiation and the incidence of oxygen radical diseases in neonatology (ORDIN) in Chinese preterm infants.
A retrospective study was conducted at two hospitals in South China, involving 452 preterm infants with gestational ages less than 37 weeks. The infants were divided into early (227 cases, initiating within 48 h after birth) and late (225 cases, initiating over 48 h after birth) caffeine treatment group. Logistic regression analysis and Receiver Operating Characteristic (ROC) curves were used to evaluate the association between early caffeine treatment and the incidence of ORDIN.
The results showed that extremely preterm infants in early treatment group had a lower incidence of PIVH and ROP compared to those in the late treatment group (PIVH, 20.1% versus 47.8%, = 0.02; ROP, 70.8% versus 89.9%, = 0.025). Very preterm infants in the early treatment group had a lower incidence of BPD and PIVH compared to those in the late treatment group (BPD, 43.8% versus 63.1%, = 0.002; PIVH, 9.0% versus 22.3%, = 0.001). Moreover, VLBW infants who received early caffeine treatment exhibited a decreased incidence of BPD (55.9% versus 80.9%, = 0.000), PIVH (11.8% versus 33.1%, = 0.000), and ROP (69.9% versus 79.8%, = 0.043) compared to those in the late treatment group. Infants in the early caffeine treatment showed a reduced likelihood of PIVH (adjusted odds ratio, 0.407; 95%CI, 0.188-0.846) but did not exhibit a significant association with other terms of ORDIN. ROC analysis revealed that early initiation of caffeine treatment was associated with lower risk of BPD, PIVH, and ROP in preterm infants.
In conclusion, this study demonstrates that early initiation of caffeine treatment is associated with a decreased incidence of PIVH in Chinese preterm infants. Further prospective investigations are necessary to verify and elucidate the precise effects of early caffeine treatment on complications in preterm Chinese infants.
自2012年12月起,在中国,预防性使用咖啡因治疗早产儿呼吸暂停已获批准。本研究旨在探讨中国早产儿早期开始咖啡因治疗与新生儿氧自由基疾病(ORDIN)发病率之间的关系。
在华南地区的两家医院进行了一项回顾性研究,纳入452例孕周小于37周的早产儿。将这些婴儿分为早期(227例,出生后48小时内开始治疗)和晚期(225例,出生后48小时后开始治疗)咖啡因治疗组。采用逻辑回归分析和受试者工作特征(ROC)曲线来评估早期咖啡因治疗与ORDIN发病率之间的关联。
结果显示,与晚期治疗组相比,早期治疗组的极早产儿脑室内出血(PIVH)和视网膜病变(ROP)发病率较低(PIVH,20.1%对47.8%,P = 0.02;ROP,70.8%对89.9%,P = 0.025)。与晚期治疗组相比,早期治疗组的早产儿支气管肺发育不良(BPD)和PIVH发病率较低(BPD,43.8%对63.1%,P = 0.002;PIVH,9.0%对22.3%,P = 0.001)。此外,与晚期治疗组相比,接受早期咖啡因治疗的极低出生体重儿BPD(55.9%对80.9%,P = 0.000)、PIVH(11.8%对33.1%,P = 0.000)和ROP(69.9%对79.8%,P = 0.043)发病率降低。早期咖啡因治疗组的婴儿发生PIVH的可能性降低(调整后的优势比,0.407;95%可信区间,0.188 - 0.846),但与ORDIN的其他指标无显著关联。ROC分析显示,早期开始咖啡因治疗与早产儿BPD、PIVH和ROP的低风险相关。
总之,本研究表明,中国早产儿早期开始咖啡因治疗与PIVH发病率降低有关。需要进一步的前瞻性研究来验证和阐明早期咖啡因治疗对中国早产儿并发症的确切影响。